Synthetic Biologics Announces First Six Participants Dosed in Phase 1a Clinical Trial of SYN-020 …,

The Phase 1a study, which is now underway at Spaulding Clinical Research, LLC of West Bend, WI, is designed to evaluate safety, tolerability and …, The Phase 1a study, which is now underway at Spaulding Clinical Research, LLC of West Bend, WI, is designed to evaluate safety, tolerability and …, Read More

Scroll to Top